Viking Therapeutics VKTX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's net income?
- Viking Therapeutics (VKTX) reported net income of -$158.33M in Q1 2026.
- How has Viking Therapeutics's net income changed year-over-year?
- Viking Therapeutics's net income decreased by 247.0% year-over-year, from -$45.63M to -$158.33M.
- What is the long-term trend for Viking Therapeutics's net income?
- Over 4 years (2021 to 2025), Viking Therapeutics's net income has grown at a 59.9% compound annual growth rate (CAGR), from -$54.99M to -$359.64M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.